CCL2 and myositis disease: The alleviation of chikungunya-associated arthritis and myositis by treatment with the MCP-1/CCL-2 inhibitor Bindarit in mice [33] also strongly suggests that monocytes-macrophages, the main targets in MCP-1/CCL-2 tissue tropism, are central to muscle and joint disease.